India: Advertisement Of Drugs In India: An Overview

Last Updated: 26 September 2013
Article by Kasturika Sen

Drugs play a very significant role in the management of ailment and illness in human life and in this context; medical practitioners are given the responsibility of prescribing the various drugs required for respective ailments/illnesses for the appropriate treatment and cure of the same.

In the light of the above mentioned, the Government of India, like most countries of the world, do not treat drugs as any other consumer products and apart from defined procedures of its procurement and sale etc., it is also subject to strict limitations in the manner in which its marketing is to be carried as well.

Current Position in India

In India, the system of regulation, in order to provide checks and balances with regard to the advertisement of drugs, is provided in the Drugs and Magical Remedies (Objectionable Advertisements) Act, 1954 ("Act"). Section 3 (d) of the Act provides that "no person shall take part in the publication of any advertisement referring to any drug in terms which suggest or are calculated to lead to the use of that drug for the diagnosis, cure, mitigation, treatment or prevention of any disease, disorder or condition specified in the Schedule, or any other disease, disorder or condition (by whatsoever name called) which maybe specified in the rules made under this Act." It can be devised, from the above provision that publication of advertisement of drugs are subject to scrutiny of the above mentioned section 3 (d) of the Act in India. Therefore, publication of any advertisement referring to any drug in terms which suggest or are calculated to lead to the use of that drug for the diagnosis, cure, mitigation, treatment or prevention of any disease, disorder or condition specified in the Schedule or Rules of the Act are prohibited in India.

The Hon'ble Supreme Court of India observed in the Hamdard Dawakhana (Wakf) Lal Kuan, Delhi & Another V. Union of India & Others (1960 AIR 554), that "The object of the Act as shown by the scheme of the Act....is the prevention of self-medication and self-treatment and a curb on such advertisements is a means to achieve that end."

However, some of the most important definition of terms described in the Act are outdated and require to be revisited in order to provide relevant meaning in today's context of progress and advancement equivalent to subject matter contained in the Act.

For example, the definition of the term advertisement under section 2(a) in the Act, which includes "any notice, circular, label, wrapper, or other document, and any announcement made orally or by any means of producing or transmitting light, sound or smoke." It must be considered that in the present situation, medium of communication is not restricted to the abovementioned terms in the definition and has evolved to a large extent, especially in the genre of electronic media and therefore the shall be included in the Act and improvised accordingly to make it easier for the authorities and the person who is taking in the part of the publication of the advertisement to classify such advertisements and understand the extent of its use.

The Act also presents certain provisions wherein the advertisement of drugs can be carried out, subject to the respective conditions laid down section 14, which includes:

  1. any sign board or notice displayed by a registered medical practitioner on his premises indicating that treatment for any disease, disorder or condition specified in section 3, ;the Schedule or the rules made under this Act, is undertaken in those premises; or
  2. any treatise or book dealing with any of the matter specified in section 3 from a bona fide scientific or social standpoint; or
  3. any advertisement relating to any drug sent confidentially in the manner prescribed under section 16 only to a registered medical practitioner; or
  4. any advertisement relating to a drug printed or published by the Government; or
  5. any advertisement relating to a drug printed or published by any person with the previous sanction of the Government granted prior to the commencement of the Drugs and magic Remedies (Objectionable Advertisement) Amendment Act, 1963 (42 of 1963); although the Government may, for reasons to be recorded in writing withdraw the sanction after giving the person an opportunity of showing cause against such withdrawal.

Hence, it can be deciphered from the above that as far as advertisement of drugs directly to consumer is concerned, the same is prohibited unless there is intervention of the government (point d & e above) or in light of education material (point b) from a scientific or social point of view and the only circumstance wherein any advertisement of drugs is permitted to be provided without any restrictions is to registered medical practitioners (point c).

The prescribed manner as mentioned in point (c) above (by which an advertisement is to be provided to a registered medical practitioner), is provided under Rule 5 of the Drugs and Magical Remedies (Objectionable Advertisements) Rules, 1955, ("Rules"), wherein all the documents containing advertisements relating to drugs ought to be sent by post to registered medical practitioner by name and address of such registered medical practitioner being given and that such documents shall bear at the top, printed in indelible ink in a conspicuous manner, the words "For the use only of registered medical practitioners or a hospital or a laboratory".

It is to be noted that the prescribed manner under Rule 5 for delivery of such advertisement to the registered medical practitioner was incorporated as per the mode of communication that were in practice when the Rules were introduced. Hence the respective Rule has to be revised and include accordingly encompassing in it all the other valid mode of communication in use in the present day or provide specific limitation of use of any particular mode of communication in the light of the objective of the Act as mentioned earlier, whichever is relevant. Absence of improvisation of the relevant sections and rules causes lacuna and dilemma in performing the activities as per the Act. Clear stipulations will assist in providing a better understanding of the options available to carry out the activities as permitted by the Act.

Judicial Overview

Apart from the improvisations and amendments suggested herein, it is pertinent to mention that the Judiciary time and again clarifies the objective of the Act when such matter is brought before it, like in Amit Singh & Anr V. The State, the Hon'ble High Court of Delhi while deciding the issues i.e. whether the advertisement amounts to advertising a drug within the meaning of Section 3 of the Act or is it only informative of improved methodology and improved equipment availability of the procedure, held that "an attempt to bring to the notice of public at large about the new technology which had been innovated.., the same in no manner can be termed as an advertisement to the sale and use of any particular drug,".

In, H.T Media Ltd & Ors vs State, [CLR MC 3060/2010] it was held by the High Court of Delhi that in the instant case, admittedly no medicine is being advertised. What is stated by the advertiser is that cure for the high blood pressure and sugar is available by an Ayurvedic drug. Since the name of the drug has not been disclosed and rather the patient has been advised to contact Dr. Bengali(Kishan Malik), it cannot be said that the advertisement is for any drug to be used for diagnosis, cure, etc. etc. of any disease specified in the Schedule.

Conclusion

Although in countries like the United States of America and New Zealand, drugs to be prescribed by medical practitioners are allowed to be advertised directly to consumers/patients and are regulated by the respective department of the Government in charge of drugs in the country, the same practice is not followed or encouraged in India. It is very apparent by t he nature of the Act that there is no opportunity to share information pertaining to a drug with a consumer/patient directly by manufacturers/importers in order to prohibit self-medication. However, it is suggested that if the Act is amended in a manner to include activities, which educates the patients about drugs, it will encourage them to understand the procedure involved in the treatment administered upon them by the medical practitioners and will ensure patient compliance of the drugs prescribed to them and more importantly will assist in removing social stigma that is associated with certain diseases.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
Singh & Associates
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Singh & Associates
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions